News

Revolutionary First Implantation of Barricaid Device Achieved

Revolutionary First Implantation of Barricaid Device Achieved

First Implantation of Barricaid Device via Endoscopic Method

Intrinsic Therapeutics has recently made headlines by successfully implanting the Barricaid Annular Closure Device for the first time using an endoscopic approach. This advancement represents a significant milestone in the field of spine surgery, particularly focused on enhancing the care provided to lumbar discectomy patients who suffer from large annular defects. The goal of this innovative procedure is to drastically minimize the rate of reoperations for reherniations, which the Barricaid device has been shown to reduce by an impressive 81%.

Details of the Landmark Procedure

Renowned spine surgeon, Dr. Daniel E. Choi, MD, FAAOS, conducted this groundbreaking procedure at Gramercy Surgery Center. Utilizing his extensive experience and training, Dr. Choi exemplified how the integration of advanced technologies can redefine surgical standards. He noted, "This novel endoscopic approach to spine surgery enabled direct visualization during the discectomy and implantation of Barricaid. I am grateful that these technologies allow for harmonious integration and see this as the next advancement in patient care."

Integration of Techniques Brings Encouraging Results

Intrinsic's Chief Technology Officer, Jacob Einhorn, was present during the case and expressed his satisfaction with the seamless integration of the dualPortal® endoscopic method with the delivery of the Barricaid device. His reflections highlight the importance of maintaining standard procedural steps while ensuring the best outcomes for patients. He remarked, "For surgeons who prefer an endoscopic approach, Barricaid can preserve their discectomy outcomes and greatly reduce the risk of reherniation and reoperation." This forward-thinking technology empowers healthcare providers to enhance patient safety and return to health.

A Powerful Collaboration to Enhance Patient Care

This surgical case is particularly noteworthy as it marks the first instance of Barricaid being implanted into a patient via Amplify Surgical's dualPortal system. Andy Choi, CEO and Co-Founder of Amplify Surgical, commented on the collaboration, stating, "I am very pleased to see two unique products come together to help patients in ways never before demonstrated. By using dualPortal access, surgeons can broaden their selection of procedures performed in conjunction with an endoscope. We are extremely excited to add Barricaid to that list and look forward to continuing to support this cutting-edge combination."

Understanding the Barricaid Device and Its Impact

Barricaid is a proprietary technology specifically designed to prevent reherniation and subsequent reoperations in patients who undergo lumbar discectomy surgery with large annular defects. Over 12,000 patients have already benefited from this innovative device, which is backed by comprehensive clinical studies across a variety of patient populations. These studies include two randomized controlled trials and six single-arm investigations, demonstrating the effectiveness of Barricaid in enhancing post-operative outcomes. A notable multicenter, Level I randomized controlled trial has shown superior results when compared to discectomy alone, published in a prestigious medical journal with five-year follow-up findings.

*Note that some studies are conducted outside FDA indications; values were observed at a minimum of one year post-operation, with a minimum study size of 20 Barricaid subjects.

Frequently Asked Questions

What is the Barricaid Annular Closure Device?

The Barricaid device is designed to prevent reherniation and reduce the need for reoperations in patients who have undergone lumbar discectomy surgery.

How does the endoscopic approach benefit surgery?

This method allows for direct visualization during the surgery, enhancing precision and minimizing invasiveness, ultimately improving patient outcomes.

Why is the dualPortal® approach significant?

The dualPortal® method integrates seamlessly with the Barricaid device, allowing surgeons greater flexibility in performing procedures while maintaining typical operational standards.

Who performed the first implantation of the Barricaid device?

The procedure was conducted by Dr. Daniel E. Choi, a skilled orthopaedic spine surgeon committed to advancing patient care.

What is the track record of the Barricaid device?

Barricaid has been implanted in over 12,000 patients and has shown promising results in clinical studies, demonstrating its effectiveness and safety.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 119

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
LGT Middle East Win Highlights Patient Private Banking

Updated Category News Views 166

A trophy in Dubai is not a balance sheet, but it can be a useful calling card when the clientele measures relationships in decades rather than quarters. LGT Middle East was named Best Pure Play Private Bank at the WealthBriefing MENA Awards 2026, at a ceremony held in Dubai on November 18. For a family-owned wealth manager working with Middle Eastern families, that sort...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 123

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 30

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem

Updated Category News Views 100

A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...

Continue Reading
SciBase Sets Its 2027 AGM Nominating Committee Early

Updated Category News Views 94

Four names on a committee roster rarely make anyone pound the table, and they should not. Still, SciBase Holding has put an important bit of corporate housekeeping in place for its 2027 Annual General Meeting: the nominating committee that will handle shareholder-facing governance work ahead of the May 20 meeting in Stockholm. For a small listed medical-technology...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 153

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

bioAffinity Technologies Launches $2.66 Million Funding Initiative

Updated Category News Views 207

Exciting Funding Development Announced by bioAffinity Technologies bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a pioneering company in the field of biotechnology, has announced an exciting funding development that is set to enhance its capability in the noninvasive detection of early-stage cancer. The company has entered into a securities purchase agreement with...

Continue Reading
Wendy's Expands Its Franchise Opportunities in Tijuana

Updated Category News Views 132

Wendy's Expands Its Franchise Opportunities in Tijuana The Wendy's Company is seeking passionate and experienced franchise partners as it intensifies its expansion strategy in Tijuana and the larger Baja California region. With the aim to develop new restaurant locations, Wendy's recognizes the potential to thrive in this vibrant market. The company has planned a...

Continue Reading
Insights into Upcoming Earnings for Vail Resorts

Updated Category News Views 215

Anticipating Vail Resorts' Earnings Report Vail Resorts (NYSE: MTN) is gearing up to release its latest quarterly earnings report, and the anticipation among investors is palpable. This upcoming announcement will shed light on the company's financial performance, and many are eagerly awaiting the results. Analyst Earnings Estimates Forecasts suggest that Vail Resorts...

Continue Reading
Creatv Bio's Innovative Blood Test for Colorectal Cancer Trials

Updated Category News Views 115

Revolutionary LifeTracDx® Blood Test in Colorectal Cancer Trials Creatv Bio, a division of Creatv MicroTech, Inc., is taking significant strides in the realm of cancer diagnostics. The introduction of their LifeTracDx® blood test in collaboration with CytoDyn Therapeutics Corporation marks a promising development in assessing patient responses to innovative treatments....

Continue Reading
Freedom Mortgage Celebrates 9 Years of Excellence with STAR Award

Updated Category News Views 212

Freedom Mortgage Earns Prestigious Recognition Again Freedom Mortgage has once again made headlines by receiving the Fannie Mae Servicer Total Achievement and Rewards™ (STAR™) Performer Award for an impressive ninth consecutive year. This accolade highlights Freedom Mortgage as a leading performer in the mortgage servicing industry, particularly for its remarkable...

Continue Reading